Viewing nowCombinationClavon Tablet 625mg
Amoxicillin Hydrate 500mg · Dilute Potassium Clavulanate 212.73mg
Tablet · Prescription medication · Combination
Kujoo Pharmaceutical Co., Ltd.

MFDS item code 201701406 · Approved 2017.03.23
Treatment of respiratory, genitourinary, skin, bone, and dental infections
This medicine is effective against various respiratory infections such as acute and chronic bronchitis, pneumonia, empyema, tonsillitis, sinusitis, and otitis media. It is also used to treat urinary tract infections such as cystitis, urethritis, pyelonephritis, and gonorrhea, as well as pelvic infections. It helps treat various infectious diseases including skin and soft tissue infections, osteomyelitis, and dental infections. This drug is effective against various bacteria including Staphylococcus aureus, Escherichia coli, and Salmonella, and can also combat beta-lactamase producing strains. It is used appropriately to improve infection depending on the patient's symptoms.
The dose of this medicine should be determined based on the patient's age, body weight, renal function, and the severity of the infection. Administer at the start of a meal to minimize potential gastrointestinal intolerance. Absorption of amoxicillin/clavulanate is optimized when administered at the start of a meal. Adults: Administer 250 mg/125 mg of amoxicillin/potassium clavulanate orally 3 times daily, every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose. In patients with renal impairment, adjust the dose as appropriate according to creatinine clearance. Adults: Dose adjustments are based on the maximum recommended dose of amoxicillin. No dosage adjustment is necessary for patients with creatinine clearance (CrCl) of 30 mL/min or more. 10 ~ 30 mL/min: Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 12 hours. 10 mL/min or less: Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours. Hemodialysis: Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours, with an additional dose during dialysis and a repeat dose at the end of dialysis (because serum concentrations of both amoxicillin and clavulanate decrease).
Children aged 12 years or older or weighing 40 kg or more: Administer 250 mg/125 mg of amoxicillin/potassium clavulanate orally 3 times daily, every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose. Children: Reduce the dose in the same manner.
This drug should not be administered to patients with hypersensitivity to beta-lactam antibiotics or a history of allergy to penicillin-related drugs. Patients with viral diseases such as infectious mononucleosis or lymphocytic leukemia should use this drug with caution due to the increased risk of skin rash. Patients with a previous history of liver dysfunction or jaundice caused by this drug or penicillin should avoid its use due to the risk of recurrence. Patients with impaired liver function should be monitored carefully as liver function may deteriorate further with this drug. Patients with moderate to severe renal impairment may require dosage adjustments due to prolonged drug retention and possible side effects. Patients with allergic tendencies or family history of allergies should use this drug cautiously as allergic reactions can occur more readily. If gastrointestinal symptoms such as vomiting or diarrhea are present, effective absorption may be compromised, so caution is advised. This drug can cause various gastrointestinal adverse reactions such as gastrointestinal disturbances, diarrhea, vomiting, and abdominal pain; in severe cases, serious colitis such as pseudomembranous colitis may occur, so if symptoms arise, immediate discontinuation and consultation with a physician are necessary. Elevated liver enzyme levels or rare liver abnormalities such as hepatitis and cholestatic jaundice may rarely occur, particularly in the elderly or males, necessitating regular liver function tests. Rarely, serious allergic reactions may appear on the skin, and if symptoms such as itching, rash, blisters, or mucosal damage occur, the drug should be discontinued immediately and medical advice sought. Blood abnormalities such as leukopenia, thrombocytopenia, and anemia have been rarely reported, so monitoring through blood tests is recommended. Central nervous system adverse reactions may include anxiety, agitation, confusion, drowsiness, and seizures, which should be reported to healthcare professionals if they occur. Renal function may deteriorate rapidly, so patients with kidney disease should have regular monitoring of renal function. This drug may affect the balance of intestinal bacteria, possibly leading to fungal infections like candidiasis, so immediate notification of symptoms is vital. Rare symptoms may include bleeding tendencies due to vitamin K deficiency or symptoms of vitamin B group deficiency, so nutritional status should be checked during long-term use. While using this drug, it is important to administer it for the minimum necessary period to prevent bacterial resistance; prolonged use may result in the emergence of resistant strains. If severe hypersensitivity occurs, anaphylactic shock may develop, so careful monitoring of the patient is required post-administration, and preparations for emergency interventions should be in place. If diarrhea occurs during antibiotic use, the possibility of pseudomembranous colitis should be considered; therefore, discontinuation and appropriate treatment must be sought immediately. This drug is excreted via the kidneys, so patients with renal impairment should adjust their dosage and administration intervals; caution should also be exercised for the elderly. Administration should be avoided during the first three months of pregnancy, and lactating mothers should discontinue use if adverse reactions occur since this drug can be transmitted through breast milk and cause side effects in infants. This drug is not recommended for children under 12 years of age or weighing less than 40 kg. In cases of overdose, symptoms such as vomiting, diarrhea, and abdominal pain may arise; in severe cases, renal failure or seizures may occur, requiring immediate appropriate medical treatment. This drug should be stored in a dry place below 25 degrees and should be discussed with healthcare professionals for possible interactions when combined with other medications.
Diarrhea, pseudomembranous colitis, dyspepsia, stomatitis, gastritis, glossitis, black hairy tongue, nausea, vomiting, loss of appetite, abdominal pain, abdominal bloating, constipation, colonic pain, hyperacidity, loose stools, dry mouth, acute pancreatitis, candidiasis, antibiotic-induced colitis, severe colitis with bloody diarrhea, increased AST, increased ALT, increased ALP, increased LDH, elevated serum bilirubin, hepatitis, cholestatic jaundice, itching, erythema multiforme, mucocutaneous syndrome, toxic epidermal necrolysis, vesiculobullous dermatitis, acute generalized pustular dermatosis, drug reactions associated with eosinophilia and systemic symptoms, angioedema, anaphylaxis, serum sickness-like syndrome, hypersensitivity vasculitis, respiratory distress associated with bronchospasm, laryngeal edema, anaphylactic shock, reversible leukopenia, reversible thrombocytopenia, hemolytic anemia, anemia, thrombocytopenic purpura, eosinophilia, leukemia, agranulocytosis, lymphocytopenia, thrombocytosis, bone marrow suppression, prolonged bleeding time, prolonged prothrombin time, mucosal candidiasis, vaginal itching, vaginal burning, increased discharge, restlessness, anxiety, behavioral changes, confusion, drowsiness, insomnia, reversible hyperactivity, dizziness, headache, convulsions, anti-parkinsonism, fever, aseptic meningitis, acute renal failure, interstitial nephritis, hematuria, crystalluria, symptoms of vitamin K deficiency, symptoms of vitamin B deficiency, linear IgA disease, dysgeusia, fatigue, dermatitis, oral edema, stomach pain, fluid and electrolyte imbalance, rash, hyperactivity, drowsiness, reduced urine output, renal failure, epileptic seizures, hypersensitivity shock, skin reactions, bleeding, pancytopenia
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent moisture and kept in a cool place between 1 and 25 degrees Celsius. Avoid direct sunlight and humidity to maintain the medication's effectiveness for a longer period.
This medicine is a white or almost white oval film-coated tablet.
4 tablets/PTP, 40 tablets/box [4 tablets/PTP * 10]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAmoxicillin Hydrate 500mg · Dilute Potassium Clavulanate 212.73mg
Tablet · Prescription medication · Combination
Kujoo Pharmaceutical Co., Ltd.
CombinationAmoxicillin Hydrate 500mg · Dilute Potassium Clavulanate 215.52mg
Tablet · Prescription medication · Combination
Geonil Pharmaceutical Co., Ltd.
CombinationAmoxicillin Hydrate 125mg · Dilute Potassium Clavulanate 107.76mg
Tablet · Prescription medication · Combination
Geonil Pharmaceutical Co., Ltd.
CombinationAmoxicillin Hydrate 250mg · Dilute Potassium Clavulanate 212.73mg
Tablet · Prescription medication · Combination
International Pharmaceutical Co., Ltd.
CombinationAmoxicillin Hydrate 250mg · Dilute Potassium Clavulanate 215.52mg
Tablet · Prescription medication · Combination
HLB Pharmaceutical Co., Ltd.
CombinationAmoxicillin Hydrate 500mg · Dilute Potassium Clavulanate 215.52mg
Tablet · Prescription medication · Combination
HLB Pharmaceuticals Co., Ltd.
CombinationAmoxicillin Hydrate 250mg · Dilute Potassium Clavulanate 215.52mg
Tablet · Prescription medication · Combination
Dong Sung Pharmaceutical Co., Ltd.
CombinationAmoxicillin Hydrate 250mg · Dilute Potassium Clavulanate 212.73mg
Tablet · Prescription medication · Combination
Youngjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.